1h Free Analyst Time
The small molecule api market is forecasted to grow by USD 67.3 billion during 2023-2028, accelerating at a CAGR of 7.5% during the forecast period. The report on the small molecule api market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by evolving small-molecule api manufacturing scenario in developing countries, increasing number of type ii drug master files (DMFs), and growing need to focus on core competencies.
The small molecule api market is segmented as below:
By Deployment
- Captive APIs
- Contract APIs
By Geographical Landscape
- North America
- Asia
- Europe
- Rest of World (ROW)
The report on the small molecule api market covers the following areas:
- Small Molecule API Market sizing
- Small Molecule API Market forecast
- Small Molecule API Market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Five Forces Analysis
7 Market Segmentation by Deployment
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global small molecule api market: Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Cambrex Corp., Cipla Inc., Corden Pharma International GmbH, Dishman Carbogen Amcis Ltd., Dr Reddys Laboratories Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson Matthey Plc, Lonza Group Ltd., Merck KGaA, Novartis AG, Novasep Holding SAS, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., Viatris Inc., and WuXi AppTec Co. Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing geriatric population."
According to the report, one of the major drivers for this market is the evolving small-molecule api manufacturing scenario in developing countries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amneal Pharmaceuticals Inc.
- Aurobindo Pharma Ltd.
- Cambrex Corp.
- Cipla Inc.
- Corden Pharma International GmbH
- Dishman Carbogen Amcis Ltd.
- Dr Reddys Laboratories Ltd.
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Johnson Matthey Plc
- Lonza Group Ltd.
- Merck KGaA
- Novartis AG
- Novasep Holding SAS
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Thermo Fisher Scientific Inc.
- Viatris Inc.
- WuXi AppTec Co. Ltd.
